SCHEMBL19575436

SCHEMBL19575436

CCc1ccc(Nc2nccc(-c3cccnc3)n2)c(C)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 11/20 0.62
BCR P11274 8/20 0.62
PRKCA P17252 5/20 0.61
KIT P10721 6/20 0.59
PDGFRA P16234 6/20 0.57
PDGFRB P09619 4/20 0.57
EGFR P00533 5/20 0.55
PRKCD Q05655 3/20 0.55
JAK3 P52333 1/20 0.53
BTK Q06187 1/20 0.53
ITK Q08881 1/20 0.53
SRC P12931 1/20 0.52
PRKACA P17612 1/20 0.52
PRKACG P22612 1/20 0.52
PRKACB P22694 1/20 0.52
PRKD3 O94806 1/20 0.52
PRKCG P05129 1/20 0.52
PRKCB P05771 1/20 0.52
LCK P06239 1/20 0.52
PRKCH P24723 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12626986 0.91 ABL1 (0.72) ABL1BCRPRKCAKITPDGFRA
SCHEMBL21004293 0.88 ABL1 (0.62) ABL1BCRPRKCAKITPDGFRA
SCHEMBL22628286 0.86 ABL1 (0.70) ABL1BCRPRKCAKITPDGFRA
SCHEMBL3860532 0.84 ABL1 (0.83) ABL1BCRPRKCAKITPDGFRA
SCHEMBL7475710 0.83 ABL1 (0.71) ABL1BCRPRKCAKITPDGFRA
SCHEMBL21004291 0.83 ABL1 (0.64) ABL1BCRPRKCAKITPDGFRA
SCHEMBL7528647 0.82 ABL1 (0.72) ABL1BCRPRKCAPDGFRAPDGFRB
SCHEMBL21004289 0.82 ABL1 (0.62) ABL1BCRPRKCAKITPDGFRA
SCHEMBL4373707 0.82 ABL1 (0.72) ABL1BCRPRKCAKITPDGFRA
SCHEMBL17782807 0.80 ABL1 (0.77) ABL1BCRPRKCAKITPDGFRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3452465-B1 SUBSTITUTED 2, 4-DIAMINO-QUINOLINE DERIVATIVES FOR USE IN THE TREATMENT OF PROLIFERATIVE DISEASES GENOSCIENCE PHARMA (FR) 2020-11-04 EP disclosed
WO-2017191599-A1 SUBSTITUTED 2, 4-DIAMINO-QUINOLINE DERIVATIVES FOR USE IN THE TREATMENT OF PROLIFERATIVE DISEASES GENOSCIENCE PHARMA (FR) 2017-11-09 WO disclosed